After the Straits Times Index (STI) retraced and managed to stay above the 3200 support level back in May 2017, the STI looks to be consolidating before continuing on its next leg of uptrend.
In our previous article, we highlighted the ‘Yay’ and ‘Nay’ sectors that investors should invest in or avoid in the Singapore market. In this article, we will look at the four alpha picks that CIMB Research recommends going into 2H17.
Following Singapore Airlines (SIA; SGX: C6L) CEO's promise to make a "bold" move to ensure the company's "long-term viability", it was recently reported that SIA is cutting jobs. It shouldn't come as a surprise.
Last Thursday (18 May 2017), SIA reported $138 million loss for the fourth quarter, the first loss-making quarter in five years. SIA's CEO Goh Choon Phong announced that he will make some "bold moves" to make SIA viable. Will it work?
Following the closing of FY16 and related announcements, March has been a month of research and stock picking among investors as everyone makes a quarterly reassessment of our positions in the stock market and also screen for new opportunities in the market.
In this article, we will be looking across the causeway to present the opportunities available for investors as growth remains strong in the country’s aviation industry.
A boy with a straw and a spitball can start a war involving guns and grenades. Earlier this week, the American government fired a spitball. On Tuesday, the U.S. government announced that air travellers from ten cities in the Middle East would not be permitted to carry electronic items any larger than a phone into the cabin on flights bound for the U.S.
Increased competition from Chinese and Middle Eastern airlines have raised serious doubts about the survival of Asian airlines such as Singapore Airlines and Cathay Pacific. However, it is not all gloom and doom for the aviation industry of Singapore.
Since the discovery of the first case of locally-transmitted Zika on August 28th, the virus is spreading across Singapore rapidly. To make matters worse, the lack of vaccine and specific treatment for the virus makes it hard to prevent or contain the situation.
Following reviews of company performance over 2Q16, UOB Kay Hian Research (UOBKH) released its top four conviction picks for the month of September. These picks have a short investment horizon of one to three months coupled with near-term share price catalysts.